홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Potassium Hydroxide → N-({4-chloro-3-[(3-chloro-5-cyanophenyl)oxy]-2-fluorophenyl}methyl)-4-({[(1,1-dimethylethyl)(dimethyl)silyl]oxy}methyl)-1-({[2-(trimethylsilyl)ethyl]oxy}methyl)-1H-imidazole-2-carboxamide

HRID 1875214
인쇄

반응식

HRID 1875214 반응식
[CH3:1][C:2]([Si:5]([CH3:27])([CH3:26])[O:6][CH2:7][C:8]1[N:9]=[C:10]([C:21](OCC)=[O:22])[N:11]([CH2:13][O:14][CH2:15][CH2:16][Si:17]([CH3:20])([CH3:19])[CH3:18])[CH:12]=1)([CH3:4])[CH3:3].[OH-].[K+].[NH2:30][CH2:31][C:32]1[C:33]([F:49])=[C:34]([O:39][C:40]2[CH:41]=[C:42]([CH:45]=[C:46]([Cl:48])[CH:47]=2)[C:43]#[N:44])[C:35]([Cl:38])=[CH:36][CH:37]=1.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CCN(C(C)C)C(C)C.C([O-])(O)=O.[Na+]>C(O)C.CN(C=O)C>[Cl:38][C:35]1[CH:36]=[CH:37][C:32]([CH2:31][NH:30][C:21]([C:10]2[N:11]([CH2:13][O:14][CH2:15][CH2:16][Si:17]([CH3:18])([CH3:19])[CH3:20])[CH:12]=[C:8]([CH2:7][O:6][Si:5]([C:2]([CH3:3])([CH3:1])[CH3:4])([CH3:27])[CH3:26])[N:9]=2)=[O:22])=[C:33]([F:49])[C:34]=1[O:39][C:40]1[CH:41]=[C:42]([C:43]#[N:44])[CH:45]=[C:46]([Cl:48])[CH:47]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

9

반응물 6

HCID 14797Potassium HydroxideHCID 81531DiisopropylethylamineHCID 516892Sodium BicarbonateHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 594513923-{[3-(Aminomethyl)-6-chloro-2-fluorophenyl]oxy}-5-chlorobenzonitrile
HCID 70937136
Ethyl 4-({[(1,1-dimethylethyl)(dimethyl)silyl]oxy}methyl)-1-({[2-(trimethylsilyl)ethyl]oxy}methyl)-1H-imidazole-2-carboxylate

생성물 1

HCID 70937189N-({4-chloro-3-[(3-chloro-5-cyanophenyl)oxy]-2-fluorophenyl}methyl)-4-({[(1,1-dimethylethyl)(dimethyl)silyl]oxy}methyl)-1-({[2-(trimethylsilyl)ethyl]oxy}methyl)-1H-imidazole-2-carboxamide수율 58%

시약·촉매·용매 2

HCID 702Ethanol용매HCID 6228Dimethylformamide용매

실험 절차

A solution of ethyl 4-({[(1,1-dimethylethyl)(dimethyl)silyl]oxy}methyl)-1-({[2-(trimethylsilyl)ethyl]oxy}methyl)-1H-imidazole-2-carboxylate (0.201 g, 0.49 mmol) in 6N KOH (0.10 mL, 0.6 mmol) and ethanol (1.5 mL) was stirred at RT for 30 mins and evaporated to dryness. The residue was stirred with 3-{[3-(aminomethyl)-6-chloro-2-fluorophenyl]oxy}-5-chlorobenzonitrile (0.10 g, 0.32 mmol), HATU (0.203 g, 0.53 mmol) and DIEA (0.085 mL, 0.49 mmol) in DMF (3 mL) at RT overnight. Sat'd NaHCO3 was added and the aqueous layer was extracted with CH2Cl2. The organic phase was dried (Na2SO4), filtered, and purified by silica gel chromatography (0-50% EtOAc/hex) to afford N-({4-chloro-3-[(3-chloro-5-cyanophenyl)oxy]-2-fluorophenyl}methyl)-4-({[(1,1-dimethylethyl)(dimethyl)silyl]oxy}methyl)-1-({[2-(trimethylsilyl)ethyl]oxy}methyl)-1H-imidazole-2-carboxamide (0.13 mg, 58%) as a brown oil and as a mixture of the expected two isomers. This material was stirred in TBAF (2 mL of a 1N solution in THF, 0.2 mmol) for 1 h. Sat'd NaHCO3 was added and the aqueous layer was extracted with CH2Cl2. The residue was stirred with TFA (0.4 mL) in EtOH (0.02 mL) and CH2Cl2 (0.8 mL) for 8 h and the solution was evaporated and purified by silica gel chromatography (0-100% EtOAc/hexs, then 0-5% MeOH (2M NH3)/CH2Cl2) to provide the title compound (0.0163 g, 20%) as a white solid. 1H NMR (400 MHz, METHANOL-d4) δ ppm 7.55 (t, J=1.51 Hz, 1H), 7.35-7.43 (m, 2 H), 7.28 (t, J=2.06 Hz, 1H), 7.22-7.26 (m, 1H), 7.15 (br. s., 1H), 4.64 (s, 2H), 4.57 (s, 2H). ES-LCMS: m/z 435.1, 437.0 (M+1).

후처리

  1. customevaporated to dryness
  2. extractionthe aqueous layer was extracted with CH2Cl2
  3. dry with materialThe organic phase was dried (Na2SO4)
  4. filtrationfiltered
  5. custompurified by silica gel chromatography (0-50% EtOAc/hex)

출처 및 근거

ORD 기록
ord-e8ad96ed8e854c69868e77048030a731
출처 데이터셋
uspto-grants-2012_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08304419B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트